Wednesday, 16th Nov 2022
6:30 – 7:30 pm AEDT (GMT +11) | 3:30pm – 4:30pm (GMT+8)
View other time zones
At the heart of the discussion on diabetes, this webinar will discuss the latest updates on the mangement of heart failure, particularly the importance of cardiovascular risk assessment for your type 2 diabetes mellitus patients. With the new CVD risk assessment tools available, we will have a heart-to-heart discussion with our experts as they share how these biomarker tools might best be applied to clinical practice.
We look forward to you joining us at the live webinar!
Who should attend:
Cardiologist, Endocrinologist, Pathologist, Cardiology advanced Trainees, GP’s, Geriatricians, Basic Physician trainees
Key reasons to attend:
- To learn about the Latest advances and management of Heart failure.
- To understand the value of NT-proBNP in clinical use.
- To know the clinical approach of managing patients with Acute and Chronic Heart Failure.
- To be aware on the guidelines on usage of NT-proBNP.
- To hear from APAC Endocrinologist on real world clinical implementation of NT-proBNP in T2DM patients
Agenda
TIME
TOPIC
SPEAKERS
18:30 – 18:45
Welcome and Latest advances in Heart Failure management in Australia
Prof. Andrew Sindone
18:45 – 19:00
Early NT proBNP testing in Acute and Chronic Heart Failure
A/ Prof. Christine Burdeniuk
19:00 – 19:15
Potential role of NT proBNP as a predictor of Future risk of Heart Failure in Type 2 Diabetes Mellitus of Heart Failure
Prof. Jonathan Shaw
19:15 – 19:30
Q&A and closing
All
